Back

Application of the 2019 ESC/EAS dyslipidemia guidelines to a Mexican population: evaluating treatment targets for secondary prevention in clinical practice

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Risk Factors and Prevention ePosters Drug therapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Cesar Ivan Laguna Munoz

Centenary Miguel Hidalgo Hospital, Aguascalientes (Mexico)

224 More presentations in this session

Presentation thumbnail
High risk characteristics in patients with hypertrophic cardiomiyopathy for predicting cardiovascular events
Doctor B. Keskin Meric (London, GB)
Abstract Slides
Presentation thumbnail
Cardiac biomarkers as prognosticators among SARS-CoV-19 patients in a tertiary hospital in Philippines
Doctor R. Ong (Makati, PH)
Abstract Slides
Presentation thumbnail
Prevalence of atherosclerosis risk factors in Egyptian patients with acute coronary syndromes; final data of the nationwide cross-sectional CardioRisk project
Doctor A. Bendary (Benha, EG)
Abstract Slides
Presentation thumbnail
SF-12 Physical and Mental Health Scales predict cardiovascular events after hospitalization
Mr R. Gascuena (Leganes, ES)
Abstract Slides
Presentation thumbnail
Comparison of traditional versus artificial intelligence based coronary artery disease risk prediction scores in young patients with acute coronary syndrome
Doctor S. Vohra (Lucknow, IN)
Abstract Slides

Access the full session

Session thumbnail
Risk Factors and Prevention ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of achieving LDL cholesterol guidelines-recommended target in secondary prevention: a real-world study
27 August 2021
thumbnail
Congress Presentation
Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: results from the Rotterdam Study
30 August 2020
thumbnail
Congress Session
Hypertension management of patient with cardiometabolic comorbidities: moving from a disease-centred to a patient-centred approach
27 August 2023
thumbnail
Congress Presentation
Target populations and treatment cost for bempedoic acid and PCSK9 inhibitors: a simulation study in a contemporary CAD cohort
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources